Skip to content

Clinical trials

Completed trials in Brazil with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Not applicable Status: Completed Country / region: Brazil Clear all

2,324 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20017
20024
20037
200422
200521
200634
200745
200868
200966
201093
2011121
2012116
2013135
2014146
2015163
2016193
2017238
2018166
2019144
202085
2021114
2022106
2023106
202461
202541
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2,324

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo288
University of Sao Paulo General Hospital157
Federal University of São Paulo121
Hospital de Clinicas de Porto Alegre121
University of Nove de Julho86
Universidade Federal de Pernambuco56
Federal University of Minas Gerais54
Federal University of Health Science of Porto Alegre50
Hospital Israelita Albert Einstein47
Federal University of Rio Grande do Sul46

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity97
Pain71
Hypertension67
Low Back Pain54
Diabetes Mellitus, Type 249
Diabetes Mellitus45
Breast Neoplasms40
Stroke40
Parkinson Disease36
Coronary Artery Disease34

Trials

Showing 1 to 25 of 2,324. Each trial links to its page on Pharma Observatory.

2,224 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.